We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




AloeVera Polymer Useful for Hemorrhagic Shock

By HospiMedica staff writers
Posted on 10 Aug 2004
A fluid derived from aloe vera has shown the potential to save the lives of patients and wounded soldiers with massive blood loss, according to the results of an animal study published in the August 2004 issue of Shock.

In the animal study, rodents given a very small amount of an aloe vera-derived drag reducing polymer (DRP) had significantly longer survival time and increased systemic whole body oxygen consumption, even without resuscitation with blood or other fluids, compared to animals not receiving DRP. More...
The central ingredient of the fluid comes from the slick substance inside the leaves of the aloe vera plant. It is a mucilage, rich in polysaccharides and has a high molecular mass and specific viscoelastic properties that allow it to reduce resistance to turbulent flow when added to a fluid in minute concentrations.

"Soldiers wounded in combat often lose significant amounts of blood, and there is no practical way to replace the necessary amount of blood fast enough on the front lines,” said senior author Mitchell P. Fink, M.D., professor and chair, department of critical care medicine at the University of Pittsburgh School of Medicine (PA, USA; www.medschool.pitt.edu). "Medics would need only to carry a small amount of this solution, which could feasibly be administered before the soldier is evacuated to a medical unit or facility.”




Related Links:
U. of Pittsburgh School of Med.

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.